(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) jumped 9.06% to $25.63 at 14:08 EST on Tuesday, following the last session’s downward trend. NASDAQ is jumping 2.44% to $11,636.81, following the last session’s downward trend. This seems, so far, an all-around up trend exchanging session today.

Castle Biosciences’s last close was $23.50, 70.09% below its 52-week high of $78.58.


Today’s last reported volume for Castle Biosciences is 153621 which is 60.97% below its average volume of 393668.

The company’s growth estimates for the current quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.73%, a positive 1.63%, and a positive 5.17%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 5.41% (last week), 5.66% (last month), and 5.17% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be overbought (>=80).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $25.63 at 14:08 EST, way below its 52-week high of $78.58 and way above its 52-week low of $15.58.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way higher than its 50-day moving average of $20.98 and way below its 200-day moving average of $39.80.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here